TP53 and cancer: In in vivo experiments with lung cancer PDX, it was found that coated cationic lipid-nanoparticles entrapping miR-660 reduced cancer cell proliferation by inhibiting MDM2 and restoring p53 function and its downstream effectors such as p21 (Moro et al., 2019).